Mike Jackson

Mike Jackson is a corporate finance partner and head of our Birmingham office. Having been in house at BGF and blue chip corporates AstraZeneca and QinetiQ advising on divestment strategy, Mike is passionate about understanding what drives clients commercially to better support their approach to transactions and deliver the right commercially minded advice.

Mike has extensive experience advising on tech and tech-enabled corporates, institutional investors and high-growth tech companies on M&A and growth capital. Mike advises a number of institutional private equity and growth capital investors and is focussed on supporting high growth business with their plans and ultimately to exit.

Mike’s recent experience includes:

• Advised the shareholders of Tisski, a Microsoft Business applications partner focussing on Public Sector cloud solutions, on their sale to private equity backed Node4.
• Advised Obsequio Group on a minority investment by Beech Tree Private Equity and its subsequent buy and build strategy.
• Advised NTT Data on its strategic acquisition of Sapphire’s US, UK and international operations to further its goal to become a premier provider in the SAP SI market for major clients, both in the UK and US.
• Advised management shareholders and minority investor Mobeus on the sale of Biosite Systems, a leader in biometric access control and software solutions for the UK construction industry on its disposal to Assa Abloy Group.